Proventil HFA Inhalation Aerosol
Company: 3M Pharmaceuticals
Approval Status: Approved June 1999
Treatment for: Pulmonary/Respiratory Diseases
Areas: Pulmonary/Respiratory Diseases
General Information
Other Useful Resources
The approval of Proventil HFA (albuterol sulfate) Inhalation Aerosol covers a supplemental new drug application that provides for the following: lowering the age from 12 years to 4 years and older for the treatment or prevention of
- bronchospasm with reversible obstructive airway disease
- exercise-induced bronchospasm
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
